Phytochemical screening, and assessment of ameliorating effect of aqueous and ethanolic extracts of Gmelina arborea on drug induced hepatic and renal insufficiency in rats

Phytochemical screening of stem bark and leaves of gmelina arborea; and effect of aqueous and ethanolic extracts of gmelina arborea stembark on hepatic and renal insufficiency in rats was assessed in this study. phytochemical screening was carried out on the air-dried leaf, oven-dried leaf, air-dried stembark and oven-dried stembark samples. sixty five (65) wister albino rats, (50.7-117.5g) were divided into thirteen groups of five animals each. three groups serve as controls and were administered cisplatin (5mg/kg b.w; i.p), paracetamol (200mg/kg b.w; i.p) and normal saline (0.002ml/kg b.w; oral). other groups were administered, either, cisplatin and extracts (1g/kg b.w; oral); paracetamol and extracts (1g/kg b.w; oral); extracts alone; or drugs and combination of extracts. animals were starved, 24 hours prior to sacrifice and sacrificed on the 9th day after commencement of treatment. phytochemical screening results show the presence of alkaloid, flavonoid, tannin, saponin, cyanogenic glycoside, phytate, and carbohydrate. saponin and carbohydrate were shown to be much higher in concentration than other phytochemicals. the percentage composition of cyanogenic glycoside and phytate were highest in air-dried stembark and oven-dried leaf samples, respectively. all the gmelina arborea extracts and extract mixture administered to both paracetamol and cisplatin treated animals, significantly, lowers both the activities of the sgot and sgpt, and the levels of serum creatinine and urea. when administered alone, the aqueous and ethanolic extracts show little or no sign of toxicity. thus gmelina arborea extracts may have ameliorating effect on hepatic and renal insufficiency caused by paracetamol and cisplatin respectively, and any inherent toxicity may be reduced or eliminated through adequate heat treatment.